Calcineurin inhibitors: Cyclosporine and Tacrolimus
To understand the mechanism of action of these drugs, it is necessary to examine the normal physiological cascade of T-lymphocyte activation. Normally, calcium ions (Ca²⁺) act as activators of the intracellular enzyme calcineurin. Once activated, calcineurin removes a phosphate group (dephosphorylates) from a specific transcription factor — NF-AT (cNF-AT). In its dephosphorylated state, this factor acquires the ability to migrate into the cell nucleus. There, it binds to the promoters of corresponding genes, ultimately triggering full T-cell activation.
The action of cyclosporine and tacrolimus aims to interrupt this biochemical chain. Inside the cell, the drugs find their specific targets — immunophilins:
- Cyclosporine binds to the protein cyclophilin.
- Tacrolimus interacts with the FKBP protein (from FK506-binding protein).
The resulting complexes interact with calcineurin. This interaction causes calcium ions to no longer be able to enhance the phosphatase activity of the enzyme. As a result, dephosphorylation of the NF-AT factor does not occur; it remains in the cytoplasm and does not translocate to the nucleus. The lymphocyte activation process is reliably blocked, while the cells themselves do not die (the drugs lack direct cytotoxicity).
Specific mechanism of action of Rapamycin
Rapamycin (also known as sirolimus) is originally an antibiotic that was first isolated from streptomycete bacteria. Inside the T-lymphocyte, this drug binds to the same FKBP protein as tacrolimus. However, this is where the similarity of their mechanisms ends.
The complex formed by rapamycin and the FKBP protein has absolutely no effect on the activity of the enzyme calcineurin. Instead, its target becomes one of the most important intracellular protein kinases. This kinase is vital for activating the gene encoding the interleukin-2 receptor $\alpha$-chain (known as CD25).
By causing the inactivation of this protein kinase, rapamycin creates an insurmountable barrier to the cell's reception of the interleukin-2 (IL-2) signal. The result is a potent immunosuppressive effect comparable to the action of calcineurin inhibitors, but achieved through a fundamentally different biochemical pathway.
Glucocorticoids: systemic action and side effects
Glucocorticoids possess two extremely powerful clinical effects — anti-inflammatory and immunosuppressive. Their introduction into medical practice revolutionized the treatment of autoimmune and severe allergic diseases. They are a crucial component in the management of bronchial asthma, systemic lupus erythematosus (SLE), as well as various systemic connective tissue pathologies.
Despite their highest efficacy, the systemic use of glucocorticoids is associated with severe side effects. The main ones include:
- Development of drug tolerance.
- Ulcer formation and prominent edema.
- Pathological changes in bones and skin.
- Various endocrine disorders.
- Increased risk of infectious complications.
Modern synthetic analogues and administration methods
To overcome some of the drawbacks of natural hormones, synthetic drugs such as dexamethasone and betamethasone were created. They differ by a significantly higher clinical activity and possess a more prolonged action. A key advantage of these synthetic molecules is that they provide a powerful anti-inflammatory effect without causing undesirable sodium (Na⁺) ion retention in the body.
At the current stage of pharmacological development, the main progress in glucocorticoid use is associated with the development of topical administration forms. The use of drugs predominantly as sprays allows the active substance to be delivered directly to the inflammation site, thereby minimizing the risk of severe systemic side effects.
Clinical significance of targeted immunosuppression
The introduction of cyclosporine and its analogues into clinical practice provided grandiose progress in such a complex field of medicine as incompatible organ transplantation.
The main advantage of these immunosuppressants lies in their high specificity: they act selectively and exclusively on activated T-cells without damaging them. Furthermore, despite certain adverse reactions (including the risk of renal damage), their overall toxicity is significantly less pronounced compared to traditional cytotoxic drugs, making long-term therapy safer for the patient.
Briefly: answers to topical questions
Which specific protein kinase does the rapamycin-FKBP complex inactivate?
The rapamycin-FKBP complex inactivates the serine-threonine kinase mTOR (mammalian target of rapamycin). This protein kinase is necessary for the activation of the IL-2 receptor $\alpha$-chain gene (CD25). Blockade of this enzyme halts the cell cycle, preventing the transition of the T-lymphocyte from the resting phase (G1) to the DNA synthesis phase (S). As a result, cellular sensitivity to interleukin-2 decreases, and lymphocyte proliferation stops without affecting calcineurin.
Which drugs belong to the group of cytotoxic immunosuppressants (antimetabolites)?
Antimetabolites include azathioprine and mycophenolate mofetil. Methotrexate also belongs to antimetabolites. Mycophenolic acid is mentioned among antimetabolites, discontinuation of which is possible in severe infection. First-generation cytotoxic drugs are characterized by interference with nucleic acid precursor synthesis, disruption of DNA replication, and cell death during division.
What are the absolute contraindications to the systemic use of glucocorticoids?
The source states that dexamethasone is absolutely contraindicated during pregnancy. It is not inactivated by the placental enzyme 3β-hydroxysteroid dehydrogenase and crosses the placenta unchanged, creating a risk of side effects for the fetus. Other glucocorticoids are permissible after a risk-benefit assessment.
The synthesis of which specific cytokines is suppressed upon inhibition of the NF-AT factor by cyclosporine?
Upon inhibition of the NF-AT factor by cyclosporine, the production of interleukin-2 (IL-2) by T-helper cells is suppressed. Cyclosporine A forms a complex with cyclophilin, which inactivates calcineurin and blocks the dephosphorylation of NF-AT and its translocation into the nucleus, impairing T-cell activation.
To avoid confusing the targets: Cyclosporine binds to Cyclophilin. Tacrolimus and rapamycin bind to FKBP, but tacrolimus acts on calcineurin, whereas rapamycin blocks the IL-2 receptor signal (acting like a "Frame" blocking the signal path).
Class and exam questions
What is the difference between the mechanisms of tacrolimus and rapamycin if they share the same target?
Both bind to the intracellular protein FKBP. However, the complex with tacrolimus blocks the phosphatase calcineurin, disrupting T-cell activation, while the complex with rapamycin inactivates the protein kinase, thereby blocking the reception of the signal from interleukin-2.
Do calcineurin inhibitors cause T-lymphocyte apoptosis?
No, cyclosporine and tacrolimus disrupt the T-cell activation process (preventing the translocation of the NF-AT factor into the nucleus) but do not possess direct cytotoxicity and do not kill the cells themselves.
How are synthetic glucocorticoids superior to natural ones?
Synthetic drugs, such as dexamethasone and betamethasone, have a longer duration of action, higher anti-inflammatory potency, and, crucially, do not cause sodium ion retention in the body.
What else to study on this topic
- Structure and functions of intracellular immunophilins (cyclophilin and FKBP protein).
- Molecular mechanism of transcription factor NF-AT dephosphorylation by calcineurin.
- The role of the IL-2 receptor $\alpha$-chain gene (CD25) in the immune response cascade.
- Pathogenesis of side effects in systemic glucocorticoid therapy (mechanism of ulcer formation and bone tissue destruction).
Master the entire topic in the "Immunology" course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on "Immunosuppressants" and 723 more pages of the subject
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 23 video lessons on the subject
Other topics in the section "Immunity in defense and damage of the organism. Pathology of immunity"
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.